Suvretta Capital Management’s DexCom DXCM Stock Holding History

Suvretta Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.87M	Buy	101,980 +70,300	+222%	+$4.68M	0.13%	59
2026 Q1	$1.99M	Hold	31,680	–	–	0.05%	66
2025 Q4	$2.1M	Hold	31,680	–	–	0.04%	76
2025 Q3	$2.13M	Hold	31,680	–	–	0.05%	77
2025 Q2	$2.77M	Hold	31,680	–	–	0.08%	71
2025 Q1	$2.16M	Hold	31,680	–	–	0.08%	79
2024 Q4	$2.46M	Hold	31,680	–	–	0.08%	73
2024 Q3	$2.12M	Buy	31,680 +25,800	+439%	+$2.12M	0.07%	74
2024 Q2	$667K	Hold	5,880	–	–	0.02%	86
2024 Q1	$816K	Hold	5,880	–	–	0.03%	90
2023 Q4	$730K	Hold	5,880	–	–	0.03%	80
2023 Q3	$549K	Hold	5,880	–	–	0.03%	84
2023 Q2	$756K	Hold	5,880	–	–	0.04%	91
2023 Q1	$683K	Buy	+5,880	New	+$658K	0.03%	86

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Suvretta Capital Management's DXCM Position: Q2 2026 in Review

Suvretta Capital Management increased its DexCom (DXCM) stake by 222% in Q2 2026, buying an estimated $4.68M and bringing the position to 101,980 shares worth $6.87M. The position accounts for 0.13% of the portfolio, ranked #59.

Suvretta Capital Management first reported a position in DXCM in Q1 2023 and has held it in 14 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Suvretta Capital Management held 101,980 shares of DexCom worth $6.87M as of Q2 2026.
Suvretta Capital Management bought 70,300 DexCom shares in Q2 2026, an estimated $4.68M.
DexCom made up 0.13% of Suvretta Capital Management's portfolio in Q2 2026, its #59 holding.
Suvretta Capital Management first reported a position in DexCom in Q1 2023 and has held it in 14 quarters since.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.